CVR number 37836044
Industry 46.1800 Agents specialised in the sale of other particular products

Simulation Medical ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.7% 2.7% 2.7% 2.7% 2.7%  
Bankruptcy risk  7.0% 2.8% 10.8% 8.0% 18.9%  
Credit score (0-100)  36 59 21 30 6  
Credit rating  BBB BBB BB BB B  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  362 2,499 -1,412 -190 -1,414  
EBITDA  -55.8 484 -1,412 -191 599  
EBIT  -55.8 484 -1,412 -191 599  
Pre-tax profit (PTP)  104.3 503.7 -1,432.6 -224.7 636.5  
Net earnings  66.7 392.3 -1,124.9 -179.5 522.3  
Pre-tax profit without non-rec. items  104 504 -1,433 -225 637  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  265 657 -575 -754 -232  
Interest-bearing liabilities  1,717 4,228 4,324 3,648 998  
Balance sheet total (assets)  4,432 5,597 6,757 7,244 4,160  
Net Debt  1,638 4,080 4,087 2,215 314  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  362 2,499 -1,412 -190 -1,414  
Gross profit growth  -65.8% 591.2% 0.0% 86.6% -645.1%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,432 5,597 6,757 7,244 4,160  
Balance sheet change%  132.5% 26.3% 20.7% 7.2% -42.6%  
Added value  -55.8 483.5 -1,412.3 -191.1 599.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 -2.0 1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -15.4% 19.3% 100.0% 100.7% -42.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.2% 10.8% -22.0% -2.0% 11.0%  
ROI %  8.6% 15.8% -30.9% -3.9% 29.3%  
ROE %  28.8% 85.1% -30.3% -2.6% 9.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  6.0% 11.7% -7.8% -9.4% -5.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -2,936.7% 843.8% -289.4% -1,159.0% 52.4%  
Gearing %  648.4% 643.6% -752.2% -483.6% -430.1%  
Net interest  0 0 0 0 0  
Financing costs %  2.2% 1.3% 0.2% 1.8% 1.9%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.7 1.5 1.1 1.1 0.8  
Current Ratio  0.7 1.5 1.1 1.1 0.8  
Cash and cash equivalent  78.8 148.5 236.3 1,433.0 683.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,122.1 1,418.1 477.7 -1,014.4 -1,431.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  -56 484 -1,412 -191 599  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -56 484 -1,412 -191 599  
EBIT / employee  -56 484 -1,412 -191 599  
Net earnings / employee  67 392 -1,125 -179 522